Anadys Pharmaceuticals Inc. (ANDS: NASDAQ)
$3.70 0.01 | 0.27%
11/23/11 - 04:00 PM ET
Company Profile data is not available for ANDS.
Portfolios with ANDS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Hep C Stocks on Wall Str...
- UserSUPRATRADE Top 10 Best-Rate...
- ContributorTop 10 Buy-Rated Stocks Und...
- UserMy Portfolio- warning high...
- Userhotequities Portfolio 1
- UserSUPRATRADE NEW-BUY LIST-240...
Latest ANDS Headlines from TheStreet
- Insiders Trading CMTL, ANDS, CRI, AAPL 10.25.11 | 09:10 am
- 7 Stocks Hitting New 52-Week Highs 10.17.11 | 01:10 pm
- Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market 10.17.11 | 11:10 am
- Roche-Anadys Hookup Could Spark More Hep C Acquisitions 10.17.11 | 06:10 am
- Anadys To Be Bought by Roche for $230M 10.17.11 | 06:10 am
- Hep C Drug Updates: Vertex and Anadys 10.13.11 | 11:10 am
- Achillion CEO Needs to Deliver on Deal Talk 09.07.11 | 01:09 pm
- Insiders Trading HAIN, APKT, ANDS, DISH 01.04.11 | 09:01 am
- Insiders Trading ANDS, AAN, KRA, LAMR 12.30.10 | 09:12 am
- Insiders Trading SCCO, QRE, AAN, ANDS 12.28.10 | 04:12 pm
Press Releases for ANDS
- The Law Firm Of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc. - Business Wire 10.21.11 | 10:10 am
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Anadys Pharmaceuticals, Inc. - Business Wire 10.20.11 | 03:10 pm
- Faruqi & Faruqi, LLP Announces Investigation Of Anadys Pharmaceuticals, Inc. - Business Wire 10.19.11 | 07:10 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Anadys Pharmaceticals, Inc. - Business Wire 10.18.11 | 11:10 pm
- Ryan & Maniskas, LLP Announces Investigation Of Anadys Pharmaceuticals Inc. - Business Wire 10.17.11 | 07:10 pm
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Anadys Pharmaceuticals Inc. In Connection With The Sale Of The Company To Roche Holding AG - PR Newswire 10.17.11 | 02:10 pm
- Tripp Levy PLLC Announces Investigation Of Anadys Pharmaceuticals - Business Wire 10.17.11 | 01:10 pm
- Anadys Announces Agreement To Be Acquired By Roche - PR Newswire 10.17.11 | 08:10 am
- Anadys Announces Agreement To Be Acquired By Roche - PR Newswire 10.17.11 | 01:10 am
- Anadys Pharmaceuticals To Present At Two Upcoming Investor Conferences - PR Newswire 09.15.11 | 04:09 pm
Partner Headlines for ANDS
- Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring - Seeking Alpha 11.25.11 | 02:11 pm
- Last Week's Institutional 5% Ownership Filings By Leading Funds - Seeking Alpha 10.25.11 | 09:10 am
- Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity - Seeking Alpha 10.23.11 | 08:10 am
- Institutional 5% Ownership Filings Last Week By The World's Leading Funds - Seeking Alpha 10.18.11 | 09:10 am
- Stocks Lower at Session's Half as Europe Debt Regains Focus; Commodities Lower - NASDAQ 10.17.11 | 04:10 pm
- Mid-Day Update: Stocks Adding to Early Losses; Europe, Manufacturing Data Weigh - NASDAQ 10.17.11 | 04:10 pm
- Morning Market Movers - Benzinga 10.17.11 | 09:10 am
- Anadys Pharmaceuticals Jumps on High Volume - Benzinga 07.12.11 | 01:07 pm
- VC-Backed Life Sciences Companies Get Fresh Cash - Seeking Alpha 05.30.10 | 11:05 am
- UPDATE 1-Anadys exploring strategic options, including sale - Reuters 05.26.10 | 09:05 am